ArticleMicrobial cell factories2025
Biogenic Zinc nanoparticles: green approach to synthesis, characterization, and antimicrobial applications.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Green synthesis of Ag-Fe₂O₃ nanocomposite using Adiantum venustum D. Don. extract and evaluation of its antimicrobial and antioxidant properties.Discover nano · 2026Article
- Article
- Enhancement in Ct-DNA binding affinity and antimicrobial activity of ZnO nanoparticles via Ag-doping.Discover nano · 2026Article
- Eco-friendly synthesis of star-shaped Zn nanoparticles using Beta vulgaris peel extract and evaluation of their antibacterial, photocatalytic, and cytotoxic activities.Scientific reports · 2026Article
- Optimization and characterization of zinc oxide nanoparticles synthesized with the assistance ofBiotechnology notes (Amsterdam, Netherlands) · 2026Article
- Biosynthesized Silver Selenide Nanoparticles fromMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiogenic synthesis of zinc nanoparticles (ZnNPs) has attracted significant interest due to their unique properties and potential biological applications. Unlike chemical and physical methods, biogenic synthesis offers a greener and more eco-friendly alternative. This study explores the synthesis of zinc-based nanoparticles using two distinct bacterial strains.
resultsIn this study, zinc nanoparticles were synthesized in two forms: single-phase zinc sulfide nanoparticles (ZnS NPs) and mixed-phase zinc sulfide-oxide nanoparticles (ZnS-ZnO NPs), using Achromobacter sp. S4 and Pseudomonas sp. S6. The synthesis conditions were optimized for each strain, with pH playing a crucial role: Achromobacter sp. S4 favored basic conditions (pH 8.0) for zinc nanoparticles production, while Pseudomonas sp. S6 preferred acidic conditions (pH 4.7). TEM analysis revealed that Zn NPs from Pseudomonas sp. S6 were rod-shaped, whereas those from Achromobacter sp. S4 were spherical. Further characterization using EDX, XRD, and FTIR confirmed the successful synthesis of single phase ZnS NPs and hybride phase ZnS-ZnO NPs. Antimicrobial dose-response testing showed that single-phase ZnS NPs inhibited Klebsiella pneumoniae, while mixed-phase ZnS-ZnO NPs were effective against Staphylococcus epidermidis at 100 µg/ml based on inhibition zone measurements.Furthermore, the mixed-phase ZnS-ZnO NPs at 25 µg/ml demonstrated superior inhibition of microbial growth in sludge samples, likely due to a synergistic effect.
conclusionThe study demonstrates the successful biogenic synthesis of ZnS NPs, and ZnS-ZnO NPs using two bacterial strains, with distinct morphological and functional properties. The use of two bacterial species was to assess strain-specific differences in nanoparticle synthesis and performance. The synthesized nanoparticles exhibited promising antimicrobial and environmental remediation potential, highlighting their applicability in both biomedical and environmental fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.